Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Connor

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|June 27, 2006
Looking at biofuels and bioenergyDavid Connor, Inés Mínguez
Phlebology|August 4, 2024
Authors reply: Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agentsJoseph Gracé, David Connor, Kurosh Parsi
Phlebology|March 25, 2024
Authors reply: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closureKurosh Parsi, Joseph Grace, David Connor
Phlebology|July 21, 2019
Circulating blood cells influence the fibrinolytic capacity of clots generated in the presence of detergent sclerosantsTom Li, David Connor, Kurosh Parsi
Journal of Vascular Surgery|April 23, 2013
Profunda femoris artery aneurysm causing local deep venous thrombosisDavid Connor, Michael Sharp, Sriram Rajagopalan
BMJ Case Reports|December 15, 2025
Atraumatic grade five renal injuryPhaedra Rampersad, Silas Webb, David Connor
Reproductive Biomedicine Online|December 11, 2020
Extracellular vesicles, microRNA and the preimplantation embryo: non-invasive clues of embryo well-beingDavid Connor Hawke, Andrew John Watson, Dean Harvey Betts
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|December 15, 2010
Coil embolization of intracranial aneurysms, the LSUHSC-S experienceRaul Cardenas, David Connor, Vijayakumar Javalkar, et al.
Phlebology|May 3, 2022
Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanismsMina Kang, Anes Yang, Patricia Hannaford, et al.
Phlebology|May 27, 2021
LIPIODOL reduces the lytic activity of detergent sclerosants <i>in vitro</i>Joseph Gracé, David Connor, Lourens Bester, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|June 27, 2006
Looking at biofuels and bioenergyDavid Connor, Inés Mínguez
Phlebology|August 4, 2024
Authors reply: Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agentsJoseph Gracé, David Connor, Kurosh Parsi
Phlebology|March 25, 2024
Authors reply: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closureKurosh Parsi, Joseph Grace, David Connor
Phlebology|July 21, 2019
Circulating blood cells influence the fibrinolytic capacity of clots generated in the presence of detergent sclerosantsTom Li, David Connor, Kurosh Parsi
Journal of Vascular Surgery|April 23, 2013
Profunda femoris artery aneurysm causing local deep venous thrombosisDavid Connor, Michael Sharp, Sriram Rajagopalan
BMJ Case Reports|December 15, 2025
Atraumatic grade five renal injuryPhaedra Rampersad, Silas Webb, David Connor
Reproductive Biomedicine Online|December 11, 2020
Extracellular vesicles, microRNA and the preimplantation embryo: non-invasive clues of embryo well-beingDavid Connor Hawke, Andrew John Watson, Dean Harvey Betts
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|December 15, 2010
Coil embolization of intracranial aneurysms, the LSUHSC-S experienceRaul Cardenas, David Connor, Vijayakumar Javalkar, et al.
Phlebology|May 3, 2022
Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanismsMina Kang, Anes Yang, Patricia Hannaford, et al.
Phlebology|May 27, 2021
LIPIODOL reduces the lytic activity of detergent sclerosants <i>in vitro</i>Joseph Gracé, David Connor, Lourens Bester, et al.
Pageof 5